| Market Cap | ₹30,735Cr |
| ROE | 22.56% |
| P/E Ratio(TTM) | 31.57 |
| EPS(TTM) | 77.93 |
| P/B Ratio | 7.12 |
| Dividend Yield | 1.14% |
| Industry P/E | 33.51 |
| Book Value | 345.37 |
| Debt to Equity | 0.06 |
| Face Value | 2 |
| Parent Organisation | Ajanta Pharma Limited |
| Managing Director | Mr. Rajesh Agrawal |
| NSE Symbol | AJANTPHARM |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 59.99 | ||
| Gland Pharma | NA (0.00%) | 37.31 | ||
| Eris Lifesciences | NA (0.00%) | 47.75 | ||
| Sai Life Sciences | NA (0.00%) | 63.36 |